Fondaparinux-impurities | Pharmaffiliates

fondaparinux

Fondaparinux is used to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs. It is marketed by GlaxoSmithKline. Reference standards of Fondaparinux API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Fondaparinux - API
    [catalogue_number] => PA 33 36000
    [category_ids] => ,94,78,70,82,88,
    [chemical_name] => 
    [weight] => 1508.22
    [form] => C31H53N3O49S8
    [cas] => 104993-28-4
    [pslug] => 104993-28-4-fondaparinux-api-pa3336000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 33 36000

Fondaparinux - API


  • Catalogue No.:PA 33 36000

  • CAS :

    104993-28-4

  • Molecular Formula : C31H53N3O49S8

  • Molecular Weight : 1508.22